Sample size considerations for studies comparing survival curves using historical controls.
暂无分享,去创建一个
[1] S. George,et al. Planning the size and duration of a clinical trial studying the time to some critical event. , 1974, Journal of chronic diseases.
[2] S J Pocock,et al. The combination of randomized and historical controls in clinical trials. , 1976, Journal of chronic diseases.
[3] J. Lachin. Introduction to sample size determination and power analysis for clinical trials. , 1981, Controlled clinical trials.
[4] M H Gail,et al. Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. , 1981, Journal of chronic diseases.
[5] P K Andersen,et al. Conditional power calculations as an aid in the decision whether to continue a clinical trial. , 1987, Controlled clinical trials.
[6] R. Wittes,et al. Methodologic guidelines for reports of clinical trials. , 1985, Cancer treatment reports.
[7] A Donner,et al. Approaches to sample size estimation in the design of clinical trials--a review. , 1984, Statistics in medicine.
[8] R W Makuch,et al. Sample size considerations for non-randomized comparative studies. , 1980, Journal of chronic diseases.
[9] J M Lachin,et al. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. , 1986, Biometrics.